HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate the superiority of arginine-vasopressin (AVP) and
hydrocortisone compared with norepinephrine regarding day-30 survival and neurological
recovery in post-cardiac arrest patients with hemodynamic failure.